Recent Finacing
Recent Raise
Respicardia develops the remedē transvenous implantable neurostimulation system that stimulates the phrenic nerve via an implanted pulse generator to restore natural breathing in adults with central sleep apnea.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors